Wearable Biosensors Studied for Clinical Monitoring and Treatment
Kuehn BM JAMA. Pub. online June 23, 2016 http://jama.jamanetwork.com/article.aspx?articleid=2530653
Leggi
Breaking news
Cost-effectiveness of aflibercept, bevacizumab, and ranibizumab for diabetic macular edema treatmentanalysis from the diabetic retinopathy clinical research network comparative effectiveness trial
Ross EL, Hutton DW, JoStein JD, et al. JAMA Ophthalmol. Pub. online June 09, 2016 http://archopht.jamanetwork.com/article.aspx?articleid=2527104
Leggi
Clinical update: cardiovascular disease in diabetes mellitus atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus – Mechanisms, management, and clinical considerations
Low Wang CC, Hess CN, Hiatt WR, et al. Circulation 2016;133:2459-2502 http://circ.ahajournals.org/content/133/24/2459.abstract
Leggi
Twenty year fitness trends in young adults and incidence of prediabetes and diabetes: the CARDIA study
Chow LS, Odegaard AO, Bosch TA, et al. Diabetologia2016;59(8):1659-65 http://link.springer.com/article/10.1007/s00125-016-3969-5?wt_mc=alerts.TOCjournals
Leggi
Quantification of the type 2 diabetes risk in women with gestational diabetes: a systematic review and meta-analysis of 95,750 women
Rayanagoudar G, Hashi AA, Zamoranet J, al. Diabetologia2016;59:1403-11 http://rd.springer.com/article/10.1007%2Fs00125-016-3927-2
Leggi
Insulin pump basal adjustment for exercise in type 1 diabetes: a randomised crossover study
McAuley SA, Horsburgh JC, Ward GM, et al. Diabetologia2016;59(8):1636-44 http://link.springer.com/article/10.1007/s00125-016-3981-9?wt_mc=alerts.TOCjournals
Leggi
Diabetic macular oedema: pathophysiology, management challenges and treatment resistance
Bahrami B, Zhu M, Hong T, Chang A Diabetologia2016;59(8):1594-608 http://link.springer.com/article/10.1007/s00125-016-3974-8?wt_mc=alerts.TOCjournals
Leggi
Liraglutide and cardiovascular outcomes in type 2 diabetes
Marso SP, Daniels GH, Brown-Frandsen K, et al.; for the LEADER Steering Committee on behalf of the LEADER Trial Investigators N Engl J Med 2016, June 13 http://www.nejm.org/doi/full/10.1056/NEJMoa1603827?query=OF
Leggi
Empagliflozin and progression of kidney disease in type 2 diabetes
Wanner C, Inzucchi SE, Lachin JM, et al.; for the EMPA-REG OUTCOME Investigators N Engl J Med 2016, June 14 http://www.nejm.org/doi/full/10.1056/NEJMoa1515920?query=OF
Leggi
Is statin monotherapy the perfect polypill?
Ridker PM Circulation 2016;134:91-93 http://circ.ahajournals.org/content/134/2/91.extract
Leggi